These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 25075962

  • 1. Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer.
    Borsò E, Boni G, Galli L, Ricci S, Farnesi A, Mazzarri S, Cianci C, Mariani G, Falcone A.
    Future Oncol; 2015; 11(2):323-31. PubMed ID: 25075962
    [Abstract] [Full Text] [Related]

  • 2. Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer.
    Picciotto M, Franchina T, Russo A, Ricciardi GRR, Provazza G, Sava S, Baldari S, Caffo O, Adamo V.
    Expert Opin Pharmacother; 2017 Jun; 18(9):899-908. PubMed ID: 28449621
    [Abstract] [Full Text] [Related]

  • 3. Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspective.
    Shore ND.
    Urology; 2015 Apr; 85(4):717-24. PubMed ID: 25681834
    [Abstract] [Full Text] [Related]

  • 4. Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data.
    Ryan CJ, Saylor PJ, Everly JJ, Sartor O.
    Oncologist; 2014 Oct; 19(10):1012-8. PubMed ID: 25232039
    [Abstract] [Full Text] [Related]

  • 5. Radium-223 dichloride: a new paradigm in the treatment of prostate cancer.
    Anido Herranz U, Fernández Calvo O, Afonso Afonso FJ, Rodríguez Martínez de Llano S, Lázaro Quintela M, León Mateos L, Vázquez Estévez S, Antón Aparicio LM.
    Expert Rev Anticancer Ther; 2015 Mar; 15(3):339-48. PubMed ID: 25555355
    [Abstract] [Full Text] [Related]

  • 6. Radium-223 dichloride: a novel treatment option for castration-resistant prostate cancer patients with symptomatic bone metastases.
    McGann S, Horton ER.
    Ann Pharmacother; 2015 Apr; 49(4):469-76. PubMed ID: 25573268
    [Abstract] [Full Text] [Related]

  • 7. [Targeted radionuclide therapy for castration-resistant prostate cancer].
    Nakamura K, Ohga S, Sasaki T, Baba S, Honda H.
    Nihon Rinsho; 2014 Dec; 72(12):2181-5. PubMed ID: 25518355
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastases.
    Shirley M, McCormack PL.
    Drugs; 2014 Apr; 74(5):579-86. PubMed ID: 24610703
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Metabolism and pharmacokinetics of radium-223 in prostate cancer.
    Yeku O, Slovin SF.
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):843-9. PubMed ID: 25740232
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting bone metastases in prostate cancer: improving clinical outcome.
    Body JJ, Casimiro S, Costa L.
    Nat Rev Urol; 2015 Jun; 12(6):340-56. PubMed ID: 26119830
    [Abstract] [Full Text] [Related]

  • 16. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
    Jong JM, Oprea-Lager DE, Hooft L, de Klerk JM, Bloemendal HJ, Verheul HM, Hoekstra OS, van den Eertwegh AJ.
    Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safety.
    Nilsson S.
    Expert Opin Drug Saf; 2015 Jul; 14(7):1127-36. PubMed ID: 26022669
    [Abstract] [Full Text] [Related]

  • 20. Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma.
    Wale DJ, Viglianti BL, Gross MD, Ferretti A, Rubello D, Wong KK.
    Am J Clin Oncol; 2019 Jan; 42(1):99-106. PubMed ID: 30204613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.